PolyNovo Limited PNV.AX Stock
2.15 AUD
{{ price }}
1.415104%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Medical Devices
COUNTRY
Australia
Exchange
ASX
Market Cap
1.48B AUD
LOW - HIGH [24H]
2.1
-
2.18 AUD
VOLUME [24H]
1.68M AUD
{{ volume }}
P/E Ratio
0
Earnings per share
0 AUD
PolyNovo Limited Price Chart
PolyNovo Limited PNV.AX Financial and Trading Overview
| PolyNovo Limited stock price | 2.15 AUD |
| Previous Close | 1.52 AUD |
| Open | 1.54 AUD |
| Bid | 1.5 AUD x 0 |
| Ask | 1.51 AUD x 0 |
| Day's Range | 1.47 - 1.54 AUD |
| 52 Week Range | 1.15 - 2.71 AUD |
| Volume | 2.97M AUD |
| Avg. Volume | 2.8M AUD |
| Market Cap | 1.07B AUD |
| Beta (5Y Monthly) | 1.504214 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.25 AUD |
PNV.AX Valuation Measures
| Enterprise Value | 1.04B AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | -2.18 |
| Price/Sales (ttm) | 20.07123 |
| Price/Book (mrq) | 16.538462 |
| Enterprise Value/Revenue | 19.591 |
| Enterprise Value/EBITDA | -319.945 |
Trading Information
PolyNovo Limited Stock Price History
| Beta (5Y Monthly) | 1.504214 |
| 52-Week Change | 13.85% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.71 AUD |
| 52 Week Low | 1.15 AUD |
| 50-Day Moving Average | 1.56 AUD |
| 200-Day Moving Average | 1.9 AUD |
PNV.AX Share Statistics
| Avg. Volume (3 month) | 2.8M AUD |
| Avg. Daily Volume (10-Days) | 2.61M AUD |
| Shares Outstanding | 690.23M |
| Float | 607.29M |
| Short Ratio | N/A |
| % Held by Insiders | 16.21% |
| % Held by Institutions | 16.50% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 0.1429:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -12.49% |
| Operating Margin (ttm) | -9.18% |
| Gross Margin | 82.38% |
| EBITDA Margin | -6.12% |
Management Effectiveness
| Return on Assets (ttm) | -4.84% |
| Return on Equity (ttm) | -15.99% |
Income Statement
| Revenue (ttm) | 53.12M AUD |
| Revenue Per Share (ttm) | 0.08 AUD |
| Quarterly Revenue Growth (yoy) | 61.79% |
| Gross Profit (ttm) | 33.94M AUD |
| EBITDA | -3252579 AUD |
| Net Income Avi to Common (ttm) | -6634868 AUD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 50.53M AUD |
| Total Cash Per Share (mrq) | 0.07 AUD |
| Total Debt (mrq) | 17.89M AUD |
| Total Debt/Equity (mrq) | 28.44 AUD |
| Current Ratio (mrq) | 5.847 |
| Book Value Per Share (mrq) | 0.091 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1512127 AUD |
| Levered Free Cash Flow (ttm) | -1269348 AUD |
Profile of PolyNovo Limited
| Country | Australia |
| State | VIC |
| City | Port Melbourne |
| Address | 320 Lorimer Street |
| ZIP | 3207 |
| Phone | 61 3 8681 4050 |
| Website | https://polynovo.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 173 |
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Q&A For PolyNovo Limited Stock
What is a current PNV.AX stock price?
PolyNovo Limited PNV.AX stock price today per share is 2.15 AUD.
How to purchase PolyNovo Limited stock?
You can buy PNV.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PolyNovo Limited?
The stock symbol or ticker of PolyNovo Limited is PNV.AX.
Which industry does the PolyNovo Limited company belong to?
The PolyNovo Limited industry is Medical Devices.
How many shares does PolyNovo Limited have in circulation?
The max supply of PolyNovo Limited shares is 690.23M.
What is PolyNovo Limited Price to Earnings Ratio (PE Ratio)?
PolyNovo Limited PE Ratio is now.
What was PolyNovo Limited earnings per share over the trailing 12 months (TTM)?
PolyNovo Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the PolyNovo Limited company belong to?
The PolyNovo Limited sector is Healthcare.
PolyNovo Limited PNV.AX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| S&P/ASX ALL AUSTRALIAN 200 AXAT | 7674.7 AUD 5079.56 USD |
-1.31
|
— — | 7669.4 AUD 5076.05 USD | 7776.2 AUD 5146.73 USD | — - | — — |
| S&P/ASX SMALL ORDINARIES AXSO | 2993.9 AUD 1981.53 USD |
-0.68
|
— — | 2993.9 AUD 1981.53 USD | 3017.2 AUD 1996.96 USD | — - | — — |
| S&P/ASX 300 AXKO | 7616 AUD 5040.7 USD |
-1.29
|
— — | 7611.7 AUD 5037.86 USD | 7715.4 AUD 5106.49 USD | — - | — — |
| S&P/ASX 200 EQUAL WEIGHT AXEW | 1852.3 AUD 1225.96 USD |
-1.04
|
— — | 1852.3 AUD 1225.96 USD | 1871.7 AUD 1238.8 USD | — - | — — |
| ALL ORDINARIES AORD | 7935.7 AUD 5252.3 USD |
-1.23
|
— — | 7930.2 AUD 5248.66 USD | 8034.9 AUD 5317.96 USD | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| S&P/ASX 200 Net Total Rtn AXNT | 92286.7 AUD 61080.61 USD |
-1.3
|
— — | 92229.8 AUD 61042.95 USD | 93503.5 AUD 61885.96 USD | — - | — — |
| S&P/ASX 200 AXJO | 7665.6 AUD 5073.53 USD |
-1.3
|
— — | 7660.9 AUD 5070.42 USD | 7766.7 AUD 5140.45 USD | — - | — — |
- {{ link.label }} {{link}}